Page 31 - மூலக்கூறு பரிசோதனை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மூலக்கூறு பரிசோதனை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மூலக்கூறு பரிசோதனை Today - Breaking & Trending Today

QIAGEN launches QIAsphere cloud-based connectivity solution to enhance QIAstat-Dx capabilities in digital diagnostics


Product News: QIAGEN launches QIAsphere cloud-based connectivity solution to enhance QIAstat-Dx capabilities in digital diagnostics
17 Mar 2021
QIAGEN has launched its QIAsphere cloud-based platform that will allow labs and QIAstat-Dx users to monitor tests and instrument status remotely 24 hours a day, 7 days a week.
QIAsphere sets new standards for syndromic testing digital health, providing users with remote visibility of their testing routine. It can monitor a nearly unlimited number of instruments, providing visibility of testing routine across different hospitals or satellite labs. The continuous connectivity to QIAGEN service reduces systems downtime and enabling fast and accurate syndromic testing. Digital diagnostics and remote analytics will be crucial to bring syndromic testing closer to patients in the coming years. ....

Jean Pascal Viola , Corporate Business Development , Product News , Molecular Diagnostics , Senior Vice President , Molecular Diagnostics Business Area , Qiagen Launches Qiasphere Cloud Based Connectivity Solution To Enhance Qiastat Dx Capabilities In Digital Diagnostics Bioinformatics , Data Science , Artificial Intelligence , Cloud Based Technology , ஜீன் பாஸ்கல் வயல , பெருநிறுவன வணிக வளர்ச்சி , ப்ராடக்ட் செய்தி , மூலக்கூறு பரிசோதனை , மூத்தவர் துணை ப்ரெஸிடெஂட் , மூலக்கூறு பரிசோதனை வணிக பரப்பளவு , தகவல்கள் அறிவியல் , செயற்கை உளவுத்துறை , மேகம் அடிப்படையிலானது தொழில்நுட்பம் ,

Study finds significant variation in biomarker test utilization and treatment for non–small-cell lung cancer


Study finds significant variation in biomarker test utilization and treatment for non–small-cell lung cancer
Biomarker testing surveys specific disease-associated molecules to predict treatment response and disease progression; however its use has complicated the diagnosis of non-small-cell lung cancer (NSCLC). In a new study in
The
Journal of Molecular Diagnosis, published by Elsevier, investigators provide for the first time a complete overview of biomarker testing, spanning multiple treatment lines, in a single cohort of patients.
Using exploratory data analysis and process-mining techniques in a real-world setting, investigators identified significant variation in test utilization and treatment. They also found that while whole-genome sequencing, in which a patient s unique DNA is mapped at once, may not be a cost saving alternative to biomarker testing, as some have suggested, it may have other benefits for patients, such as decreasing the time between test ....

Maarten Ijzerman , Emily Henderson , University Of Twente , Services Research , Health Technology , University Of Melbourne Centre For Cancer Research , Techmed Center , Molecular Diagnosis , Professor Maarten , Melbourne Centre , Cancer Research , First Author , Phd Candidate , Lung Cancer , Molecular Diagnostics , எமிலி ஹென்டர்சன் , பல்கலைக்கழகம் ஆஃப் இருபது , சேவைகள் ஆராய்ச்சி , ஆரோக்கியம் தொழில்நுட்பம் , பல்கலைக்கழகம் ஆஃப் மெல்போர்ன் மையம் க்கு புற்றுநோய் ஆராய்ச்சி , தொழில்நுட்பம் மையம் , மூலக்கூறு நோயறிதல் , ப்ரொஃபெஸர் மார்டன் , மெல்போர்ன் மையம் , புற்றுநோய் ஆராய்ச்சி , முதல் நூலாசிரியர் ,